Sign inJoin waitlistJoin the waitlist

Erqi Pollom

Vice Chair, Clinical Operations, Radiation Oncology · Stanford Health Care

Credentials: · · · ·

History

Clinical Operations · Stanford Health Care
Present
Clinical Operations · Stanford Health Care
Present
Stanford Health Care
Present

Stanford University Dept of Radiation Oncology (2017) CA
2013–2017
Transitional Year
Loyola Medicine MacNeal Hospital
2012–2013
University of Michigan Medical School
2008–2012

Research

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma
Journal of Clinical Oncology · 2016 · 443 citations
Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy
Cancer · 2020 · Last of 3 authors · 148 citations
Brain Metastases in EGFR- and ALK-Positive NSCLC: Outcomes of Central Nervous System-Penetrant Tyrosine Kinase Inhibitors Alone Versus in Combination With Radiation
Journal of Thoracic Oncology · 2022 · 97 citations

Scott Soltys
81 papers
Steven Chang
53 papers
Daniel Chang
52 papers
Gordon Li
33 papers
David Park
27 papers · 27 as a resident
Elham Rahimy
25 papers · 6 as a resident
Iris Gibbs
25 papers
Antonio Meola
20 papers · 19 as a resident
CH
Caressa Hui
18 papers · 13 as a resident
Seema Nagpal
18 papers
Albert Koong
17 papers
Yusuke Hori
16 papers · 16 as a resident

Clinical trials

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
Principal investigator · Recruiting · Phase 3
Stanford University
2023–2028
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
Principal investigator · Completed · Phase 2
Stanford University
2020–2024
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Principal investigator · Terminated · Phase 3
Stanford University
2016–2022
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Site PI · Recruiting · Phase 2
Stanford University
2026–2030